초록

The present invention features novel compositions, linkers, derivatized solid supports, and methods for the efficient solid phase synthesis of oligonucleotides, including RNA, DNA, RNA-DNA chimeras, and analogs thereof.

대표청구항 ▼

What is claimed is: 1. A compound of the Formula II: wherein SP is a solid support, W is selected from the group consisting of a carboxy linkage, an amino linkage, a carboxamido linkage, a mercaptoalkyl linkage, a succinyl linkage, an oxalyl linkage, a 3′ glycolate termini linkage, an o-

What is claimed is: 1. A compound of the Formula II: wherein SP is a solid support, W is selected from the group consisting of a carboxy linkage, an amino linkage, a carboxamido linkage, a mercaptoalkyl linkage, a succinyl linkage, an oxalyl linkage, a 3′ glycolate termini linkage, an o-nitrophenyl-1,3-propanediol linkage, an alkoxybenzylidene acetal linkage, a hydroquinone-O—O′-diacetic acid linkage, and a pentachlorophenyl-succinate linkage, and B represents a terminal chemical group from which an oligonucleotide can be synthesized. 2. A compound of the Formula VI(a): wherein SP is a solid support. 3. The compound of claim 1, wherein said B comprises a nucleic acid, nucleoside, nucleotide, or an abasic moiety. 4. The compound of claim 3, wherein said nucleic acid, nucleoside, nucleotide, or abasic moiety comprises an acid labile protecting group. 5. The compound of claim 4, wherein said acid labile protecting group is a dimethoxytrityl, monomethoxytrityl, or trityl group. 6. A method of synthesizing a compound of claim 1, comprising coupling a terminal chemical group comprising a nucleic acid, nucleoside, nucleotide or an abasic moiety to the primary amine of a compound of Formula VI(a): to form said compound of claim 1. 7. The method of claim 6, wherein said coupling is at a loading of about 40 to about 80 μmol/gram of said SP. 8. The method of claim 6, wherein said coupling is at a loading of about 50 to about 60 μmol/gram of said SP. 9. The compound of claim 1, wherein said SP is a controlled pore glass support. 10. The compound of claim 2, wherein said SP is a controlled pore glass support. 11. The compound of claim 1, wherein said W is a succinyl linkage. 12. The compound of claim 2, wherein said W is a succinyl linkage. 13. The compound of claim 11, wherein said B is an abasic moiety. 14. The compound of claim 11, wherein said B is selected from adenosine, cytidine, guanosine, thymidine, or uridine. 15. The compound of claim 13, wherein said abasic succinate is a 5′-O-succinyl-3′-O-DMT deoxyribose. 16. The compound of claim 14, wherein said adenosine succinate is a 5′-O-DMT-3′-O-succinyl adenosine with or without nitrogen protecting groups. 17. The compound of claim 14, wherein said cytidine succinate is a 5′-O-DMT-3′-O-succinyl cytidine with or without nitrogen protecting groups. 18. The compound of claim 14, wherein said guanosine succinate is a 5′-O-DMT-3′-O-succinyl guanosine with or without nitrogen protecting groups. 19. The compound of claim 14, wherein said thymidine succinate is a 5′-O-DMT-3′-O-succinyl thymidine. 20. The compound of claim 14, wherein said uridine succinate is a 5′-O-DMT-3′-O-succinyl uridine.